These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

684 related items for PubMed ID: 16956403

  • 1. Distinct effects of rectum delineation methods in 3D-conformal vs. IMRT treatment planning of prostate cancer.
    Guckenberger M, Meyer J, Baier K, Vordermark D, Flentje M.
    Radiat Oncol; 2006 Sep 06; 1():34. PubMed ID: 16956403
    [Abstract] [Full Text] [Related]

  • 2. Comparison of rectal dose-wall histogram versus dose-volume histogram for modeling the incidence of late rectal bleeding after radiotherapy.
    Tucker SL, Dong L, Cheung R, Johnson J, Mohan R, Huang EH, Liu HH, Thames HD, Kuban D.
    Int J Radiat Oncol Biol Phys; 2004 Dec 01; 60(5):1589-601. PubMed ID: 15590191
    [Abstract] [Full Text] [Related]

  • 3. Use of benchmark dose-volume histograms for selection of the optimal technique between three-dimensional conformal radiation therapy and intensity-modulated radiation therapy in prostate cancer.
    Luo C, Yang CC, Narayan S, Stern RL, Perks J, Goldberg Z, Ryu J, Purdy JA, Vijayakumar S.
    Int J Radiat Oncol Biol Phys; 2006 Nov 15; 66(4):1253-62. PubMed ID: 17145540
    [Abstract] [Full Text] [Related]

  • 4. Pilot study of conformal intensity modulated radiation therapy for localized prostate cancer.
    Aillères N, Azria D, Thézenas S, Barbier N, Fenoglietto P, Delard R, Hay MH, Dubois JB.
    Cancer Radiother; 2004 Apr 15; 8(2):59-69. PubMed ID: 15063872
    [Abstract] [Full Text] [Related]

  • 5. Anal wall sparing effect of an endorectal balloon in 3D conformal and intensity-modulated prostate radiotherapy.
    Smeenk RJ, van Lin EN, van Kollenburg P, Kunze-Busch M, Kaanders JH.
    Radiother Oncol; 2009 Oct 15; 93(1):131-6. PubMed ID: 19523704
    [Abstract] [Full Text] [Related]

  • 6. Persistently better treatment planning results of intensity-modulated (IMRT) over conformal radiotherapy (3D-CRT) in prostate cancer patients with significant variation of clinical target volume and/or organs-at-risk.
    Fenoglietto P, Laliberte B, Allaw A, Ailleres N, Idri K, Hay MH, Moscardo CL, Gourgou S, Dubois JB, Azria D.
    Radiother Oncol; 2008 Jul 15; 88(1):77-87. PubMed ID: 18215434
    [Abstract] [Full Text] [Related]

  • 7. Dosimetric and radiobiologic comparison of 3D conformal versus intensity modulated planning techniques for prostate bed radiotherapy.
    Koontz BF, Das S, Temple K, Bynum S, Catalano S, Koontz JI, Montana GS, Oleson JR.
    Med Dosim; 2009 Jul 15; 34(3):256-60. PubMed ID: 19647638
    [Abstract] [Full Text] [Related]

  • 8. Dosimetry and radiobiologic model comparison of IMRT and 3D conformal radiotherapy in treatment of carcinoma of the prostate.
    Luxton G, Hancock SL, Boyer AL.
    Int J Radiat Oncol Biol Phys; 2004 May 01; 59(1):267-84. PubMed ID: 15093924
    [Abstract] [Full Text] [Related]

  • 9. Rectal wall sparing by dosimetric effect of rectal balloon used during intensity-modulated radiation therapy (IMRT) for prostate cancer.
    Teh BS, Dong L, McGary JE, Mai WY, Grant W, Butler EB.
    Med Dosim; 2005 May 01; 30(1):25-30. PubMed ID: 15749008
    [Abstract] [Full Text] [Related]

  • 10. Application of a spacer gel to optimize three-dimensional conformal and intensity modulated radiotherapy for prostate cancer.
    Pinkawa M, Corral NE, Caffaro M, Piroth MD, Holy R, Djukic V, Otto G, Schoth F, Eble MJ.
    Radiother Oncol; 2011 Sep 01; 100(3):436-41. PubMed ID: 21963289
    [Abstract] [Full Text] [Related]

  • 11. Does treatment of the pelvic nodes with IMRT increase late rectal toxicity over conformal prostate-only radiotherapy to 76 Gy?
    Sanguineti G, Cavey ML, Endres EJ, Franzone P, Barra S, Parker BC, Marcenaro M, Colman M, Agostinelli S, Foppiano F, Vitale V.
    Strahlenther Onkol; 2006 Sep 01; 182(9):543-9. PubMed ID: 16944377
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparative treatment planning on localized prostate carcinoma conformal photon- versus proton-based radiotherapy.
    Mock U, Bogner J, Georg D, Auberger T, Pötter R.
    Strahlenther Onkol; 2005 Jul 01; 181(7):448-55. PubMed ID: 15995838
    [Abstract] [Full Text] [Related]

  • 14. Volumetric modulated arc therapy (VMAT) vs. serial tomotherapy, step-and-shoot IMRT and 3D-conformal RT for treatment of prostate cancer.
    Wolff D, Stieler F, Welzel G, Lorenz F, Abo-Madyan Y, Mai S, Herskind C, Polednik M, Steil V, Wenz F, Lohr F.
    Radiother Oncol; 2009 Nov 01; 93(2):226-33. PubMed ID: 19765846
    [Abstract] [Full Text] [Related]

  • 15. A prospective three-dimensional analysis about the impact of differences in the clinical target volume in prostate cancer irradiation on normal-tissue exposure. A potential for increasing the benefit/risk ratio.
    Hille A, Töws N, Schmidberger H, Hess CF.
    Strahlenther Onkol; 2005 Dec 01; 181(12):789-95. PubMed ID: 16362789
    [Abstract] [Full Text] [Related]

  • 16. Rectal dose reduction using three-dimensional conformal radiotherapy for locally advanced prostate cancer: A combination of conformal dynamic-arc and five-static field technique.
    Sasaoka M, Nishikawa A, Futami T, Nishida K, Miwa H, Kadoya K.
    Radiother Oncol; 2009 Mar 01; 90(3):318-24. PubMed ID: 19008004
    [Abstract] [Full Text] [Related]

  • 17. Dosimetric comparison of intensity-modulated, conformal, and four-field pelvic radiotherapy boost plans for gynecologic cancer: a retrospective planning study.
    Chan P, Yeo I, Perkins G, Fyles A, Milosevic M.
    Radiat Oncol; 2006 May 04; 1():13. PubMed ID: 16722546
    [Abstract] [Full Text] [Related]

  • 18. Phase II dose escalation study of image-guided adaptive radiotherapy for prostate cancer: use of dose-volume constraints to achieve rectal isotoxicity.
    Vargas C, Yan D, Kestin LL, Krauss D, Lockman DM, Brabbins DS, Martinez AA.
    Int J Radiat Oncol Biol Phys; 2005 Sep 01; 63(1):141-9. PubMed ID: 16111582
    [Abstract] [Full Text] [Related]

  • 19. A phase II trial for the optimisation of treatment position in the radiation therapy of prostate cancer.
    O'Neill L, Armstrong J, Buckney S, Assiri M, Cannon M, Holmberg O.
    Radiother Oncol; 2008 Jul 01; 88(1):61-6. PubMed ID: 18453021
    [Abstract] [Full Text] [Related]

  • 20. Dose to bone marrow using IMRT techniques in prostate cancer patients.
    Gershkevitsh E, Clark CH, Staffurth J, Dearnaley DP, Trott KR.
    Strahlenther Onkol; 2005 Mar 01; 181(3):172-8. PubMed ID: 15756521
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.